Skip to main content
Figure 6 | Breast Cancer Research

Figure 6

From: Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors

Figure 6

Biodistribution of STL-6014 and STL-7012 in MDA-MB-231-RFP tumor-bearing mice. CD-1 nude, female mice (n = 3 for each time point) were intravenously injected with: (a) 15 mg/kg STL-6014 or, (b) 9 mg/kg STL-7012 and sacrificed at the indicated times. Tissue samples were collected for STL-6014 or STL-7012 extraction. Values represent averaged fluorescence intensities (± standard deviation), measured as described in the methods section.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us